Stemline Therapeutics Company

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Technology: Anti-infective Drugs, Stem cell therapy
Industry: PharmTech, Public
Headquarters: New York, New York, United States
Founded Date: 2003-08-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 1
Total Funding: 107090000
Estimated Revenue: $10M to $50M
Last Funding Date: 2019-01-15
Last Funding Type: Post-IPO Equity

Visit Website
info@stemline.com
Register and Claim Ownership